Quick Answer
Onconetix, Inc. reported Total Revenue of $815.4 thousand for the year ending 2025.
- Onconetix, Inc. showed a decrease of -67.7% in Total Revenue from 2024 to 2025.
- This data is from Onconetix, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $700.4 thousand | Q2 2024: $704.8 thousand | Q2 2024: $704.8 thousand | Q3 2024: $406.9 thousand | Q3 2024: $406.9 thousand | Q1 2025: $101.6 thousand | Q2 2025: $106.5 thousand | Q3 2025: $303.7 thousand.
- Over the full 3 years of available data (2023 to 2025), Onconetix, Inc.'s Total Revenue has grown by 1,294.6%.
- Historical annual values: Fiscal year 2025: $815.4 thousand | Fiscal year 2024: $2.52 million | Fiscal year 2023: $58.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: